Cargando…
Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets
The Food and Drug Administration Adverse Event Reporting System (FAERS) remains the primary source for post-marketing pharmacovigilance. The system is largely un-curated, unstandardized, and lacks a method for linking drugs to the chemical structures of their active ingredients, increasing noise and...
Autores principales: | Maciejewski, Mateusz, Lounkine, Eugen, Whitebread, Steven, Farmer, Pierre, DuMouchel, William, Shoichet, Brian K, Urban, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548487/ https://www.ncbi.nlm.nih.gov/pubmed/28786378 http://dx.doi.org/10.7554/eLife.25818 |
Ejemplares similares
-
Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets
por: Lounkine, Eugen, et al.
Publicado: (2012) -
Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches
por: van Rijt, Antonia, et al.
Publicado: (2023) -
Paving the way to metastasis
por: Van Epps, Heather L.
Publicado: (2005) -
In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
por: Refaat, Ahmed, et al.
Publicado: (2022) -
Paving the Way for Apollo 11
por: Harland, David M
Publicado: (2009)